Yi Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 111

Top Venues

Signal transduction and targeted therapy

Journal for immunotherapy of cancer

Nature immunology

British journal of cancer

Zhengzhou University First Affiliated Hospital

Universit de Louvain (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhengzhou University First Affiliated Hospital

China

Director of Biotherapy Center & Distinguished Professor at Cancer Center

Medical University of South Carolina

United States

Tenure-track Assistant Professor :: Department of Surgery

University of Chicago

United States

Research Assistant Professor :: Department of Pathology

Zhengzhou University Medical College

China

Associate Professor and Director of Liver Disease Lab

Zhengzhou University Medical College

China

Lecturer

Zhengzhou University Medical College

China

Teaching assistance

Education History

Universit de Louvain Jan 16 2002 - Jun 06 2004

Belgium

PHD

Huazhong University of Science and Technology Tongji Medical College Sep 01 1988 - Jun 15 1991

China

MSC

Publications

Jinyan Liu, Huanan Chen, Caijuan Guo, Jieyao Li, Miaomiao Li, Ming Zhao, Ziyi Fu, Zhen Zhang, Feng Li, Xuan Zhao, Li Yang, Liping Wang, Quanjun Lv, Yi Zhang
Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'. Journal for immunotherapy of cancer 12 (1) (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Congcong Li, Zhen Zhang, Qianfeng Cai, Qitai Zhao, Han Wu, JunRu Li, Yaqing Liu, Xuan Zhao, Jinyan Liu, Yu Ping, Jiqi Shan, Shengli Yang, Yi Zhang
Peripheral CX3CR1 + T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer. Oncoimmunology 13 (1) (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology 25 (3) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology (2024)
Zhen Zhang, Xuan Zhao, Qitai Zhao, Xinfeng Chen, Congcong Li, Yaqing Liu, Chunyi Shen, Lijie Song, Lijun Miao, Fuyou Guo, Xiaoning Mou, Jie Zhao, Weiyue Gu, Yi Zhang
Peripheral blood-derived PD-1/CD28-CD19-CAR-modified PD-1+ T-cell therapy in patients with solid tumors. Cancer immunology research (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer 130 (8) (2024)
Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial. Signal transduction and targeted therapy 9 (1) (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer 130 (8) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology 25 (3) (2024)
Shuman Zhen, Yunlong Jia, Yan Zhao, Jiali Wang, Boyang Zheng, Tianxu Liu, Yuqing Duan, Wei Lv, Jiaqi Wang, Fan Xu, Yueping Liu, Yi Zhang, Yunlong Jia
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell death discovery 10 (1) (2024)
Congcong Li, Zhen Zhang, Qianfeng Cai, Qitai Zhao, Han Wu, JunRu Li, Yaqing Liu, Xuan Zhao, Jinyan Liu, Yu Ping, Jiqi Shan, Shengli Yang, Yi Zhang
Peripheral CX3CR1 + T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer. Oncoimmunology 13 (1) (2024)
Jinyan Liu, Huanan Chen, Caijuan Guo, Jieyao Li, Miaomiao Li, Ming Zhao, Ziyi Fu, Zhen Zhang, Feng Li, Xuan Zhao, Li Yang, Liping Wang, Quanjun Lv, Yi Zhang
Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'. Journal for immunotherapy of cancer 12 (1) (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer 130 (8) (2024)
Congcong Li, Zhen Zhang, Qianfeng Cai, Qitai Zhao, Han Wu, JunRu Li, Yaqing Liu, Xuan Zhao, Jinyan Liu, Yu Ping, Jiqi Shan, Shengli Yang, Yi Zhang
Peripheral CX3CR1 + T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer. Oncoimmunology 13 (1) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology 25 (3) (2024)
Shuman Zhen, Yunlong Jia, Yan Zhao, Jiali Wang, Boyang Zheng, Tianxu Liu, Yuqing Duan, Wei Lv, Jiaqi Wang, Fan Xu, Yueping Liu, Yi Zhang, Yunlong Jia
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence. Cell death discovery 10 (1) (2024)
Han Wu, Junru Li, Zhen Zhang, Yi Zhang
Characteristics and mechanisms of T-cell senescence: A potential target for cancer immunotherapy. European journal of immunology (2024)
Jinyan Liu, Huanan Chen, Caijuan Guo, Jieyao Li, Miaomiao Li, Ming Zhao, Ziyi Fu, Zhen Zhang, Feng Li, Xuan Zhao, Li Yang, Liping Wang, Quanjun Lv, Yi Zhang
Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'. Journal for immunotherapy of cancer 12 (1) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology 25 (3) (2024)
Jinyan Liu, Huanan Chen, Caijuan Guo, Jieyao Li, Miaomiao Li, Ming Zhao, Ziyi Fu, Zhen Zhang, Feng Li, Xuan Zhao, Li Yang, Liping Wang, Quanjun Lv, Yi Zhang
Sulforaphane activates CD8 + T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'. Journal for immunotherapy of cancer 12 (1) (2024)
Jingwei Ma, Liang Tang, Yaoyao Tan, Jingxuan Xiao, Keke Wei, Xin Zhang, Yuan Ma, Shuai Tong, Jie Chen, Nannan Zhou, Li Yang, Zhang Lei, Yonggang Li, Jiadi Lv, Junwei Liu, Huafeng Zhang, Ke Tang, Yi Zhang, Bo Huang
Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria. Nature immunology 25 (3) (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer 130 (8) (2024)
Yaoxin Gao, Shasha Liu, Yifan Huang, Hui Wang, Yuyu Zhao, Xuyang Cui, Yajing Peng, Feng Li, Yi Zhang
CAR T cells engineered to secrete IFN-κ induce tumor ferroptosis via an IFNAR/STAT1/ACSL4 axis. Cancer immunology research (2024)
Kai Zhang, Wenhao Hu, Feng Li, Chunli Wen, Lingxiao Zhou, Lei Zhang, Jingyao Lian, Shasha Liu, Shumin Wang, Yi Zhang
IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. British journal of cancer 130 (8) (2024)
Li Zhou, Dongxiao Wu, Yabo Zhou, Dianheng Wang, Haixia Fu, Qiusha Huang, Guohui Qin, Jie Chen, Jiadi Lv, Shaoyang Lai, Huafeng Zhang, Ke Tang, Jingwei Ma, Roland Fiskesund, Yi Zhang, Xiao-Hui Zhang, Bo Huang
Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1. Nature immunology (2023)
Leilei Yang, Songya Li, Liuhui Chen, Yi Zhang
Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity. Cancer biology & medicine (2023)
Caijuan Guo, Jinyan Liu, Yi Zhang
Current advances in bacteria-based cancer immunotherapy. European journal of immunology (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Caijuan Guo, Jinyan Liu, Yi Zhang
Current advances in bacteria-based cancer immunotherapy. European journal of immunology 54 (2) (2023)
Li Yang, Aitian Li, Ying Wang, Yi Zhang
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal transduction and targeted therapy 8 (1) (2023)
Zaoqu Liu, Qimeng Liang, Yuqing Ren, Chunguang Guo, Xiaoyong Ge, Libo Wang, Quan Chen, Peng Luo, Yi Zhang, Xin-Wei Han
Immunosenescence: molecular mechanisms and diseases. Signal transduction and targeted therapy 8 (1) (2023)
Jinyan Liu, Jiayin Liu, Guohui Qin, Jiahui Li, Ziyi Fu, Jieyao Li, Miaomiao Li, Caijuan Guo, Ming Zhao, Zhen Zhang, Feng Li, Xuan Zhao, Liping Wang, Yi Zhang
MDSCs-derived GPR84 induces CD8 + T-cell senescence via p53 activation to suppress the antitumor response. Journal for immunotherapy of cancer 11 (11) (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Jiadi Lv, Yabo Zhou, Nannan Zhou, Zhenfeng Wang, Jie Chen, Haoran Chen, Dianheng Wang, Li Zhou, Keke Wei, Huafeng Zhang, Ke Tang, Jingwei Ma, Yuying Liu, Yonghong Wan, Yi Zhang, Hai-Zeng Zhang, Bo Huang
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells. Science translational medicine 15 (681) (2023)
Jiadi Lv, Yabo Zhou, Nannan Zhou, Zhenfeng Wang, Jie Chen, Haoran Chen, Dianheng Wang, Li Zhou, Keke Wei, Huafeng Zhang, Ke Tang, Jingwei Ma, Yuying Liu, Yonghong Wan, Yi Zhang, Hai-Zeng Zhang, Bo Huang
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells. Science translational medicine 15 (681) (2023)
Caijuan Guo, Jinyan Liu, Yi Zhang
Current advances in bacteria-based cancer immunotherapy. European journal of immunology 54 (2) (2023)
Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang
LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy. Oncoimmunology 13 (1) (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Li Zhou, Dongxiao Wu, Yabo Zhou, Dianheng Wang, Haixia Fu, Qiusha Huang, Guohui Qin, Jie Chen, Jiadi Lv, Shaoyang Lai, Huafeng Zhang, Ke Tang, Jingwei Ma, Roland Fiskesund, Yi Zhang, Xiao-Hui Zhang, Bo Huang
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1. Nature immunology (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Li Yang, Aitian Li, Ying Wang, Yi Zhang
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal transduction and targeted therapy 8 (1) (2023)
Zaoqu Liu, Qimeng Liang, Yuqing Ren, Chunguang Guo, Xiaoyong Ge, Libo Wang, Quan Chen, Peng Luo, Yi Zhang, Xin-Wei Han
Immunosenescence: molecular mechanisms and diseases. Signal transduction and targeted therapy 8 (1) (2023)
Li Yang, Aitian Li, Ying Wang, Yi Zhang
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal transduction and targeted therapy 8 (1) (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Jiadi Lv, Yabo Zhou, Nannan Zhou, Zhenfeng Wang, Jie Chen, Haoran Chen, Dianheng Wang, Li Zhou, Keke Wei, Huafeng Zhang, Ke Tang, Jingwei Ma, Yuying Liu, Yonghong Wan, Yi Zhang, Hai-Zeng Zhang, Bo Huang
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells. Science translational medicine 15 (681) (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang
LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy. Oncoimmunology 13 (1) (2023)
Guohui Qin, Shasha Liu, Jinyan Liu, Hongwei Hu, Li Yang, Qitai Zhao, Congcong Li, Bin Zhang, Yi Zhang
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells. Signal transduction and targeted therapy 8 (1) (2023)
Keke Wei, Huafeng Zhang, Shuaishuai Yang, Yuxiao Cui, Bingxia Zhang, Jincheng Liu, Liang Tang, Yaoyao Tan, Simin Liu, Shiqi Chen, Wu Yuan, Xiao Luo, Chen Chen, Fei Li, Junwei Liu, Jie Chen, Pingwei Xu, Jiadi Lv, Ke Tang, Yi Zhang, Jingwei Ma, Bo Huang
Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1. Signal transduction and targeted therapy 8 (1) (2023)
Li Yang, Aitian Li, Ying Wang, Yi Zhang
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal transduction and targeted therapy 8 (1) (2023)
Yonggui Tian, Chunli Wen, Zhen Zhang, Yanfen Liu, Feng Li, Qitai Zhao, Chang Yao, Kaiyuan Ni, Shengli Yang, Yi Zhang
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy. Cancer immunology, immunotherapy : CII 71 (11) (2022)
Yu Ping, Chunyi Shen, Bo Huang, Yi Zhang
Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity. Cells 11 (19) (2022)
Pupu Li, Xinfeng Chen, Yu Ping, Guohui Qin, Lan Huang, Qitai Zhao, Zhen Zhang, Huanan Chen, Liping Wang, Shengli Yang, Yi Zhang
Clinical Correlation of Function and TCR vβ Diversity of MAGE-C2-Specific CD8 + T Cell Response in Esophageal Cancer. Journal of immunology (Baltimore, Md. : 1950) 209 (6) (2022)
Qun Gao, Shumin Wang, Feng Li, Jingyao Lian, Shaoyan Cheng, Dongli Yue, Zhen Zhang, Shasha Liu, Feifei Ren, Daiqun Zhang, Shengdian Wang, Liping Wang, Yi Zhang
High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation. Cancer immunology research 10 (7) (2022)
Shaoyan Cheng, Feng Li, Haiming Qin, Yu Ping, Qitai Zhao, Qun Gao, Mengjia Song, Jiao Qu, Jiqi Shan, Kai Zhang, Zhen Zhang, Jingyao Lian, Shasha Liu, Liping Wang, Yi Zhang
Long Noncoding RNA lncNDEPD1 Regulates PD-1 Expression via miR-3619-5p in CD8 + T Cells. Journal of immunology (Baltimore, Md. : 1950) 208 (6) (2022)
Guohui Qin, Shasha Liu, Li Yang, Weina Yu, Yi Zhang
Myeloid cells in COVID-19 microenvironment. Signal transduction and targeted therapy 6 (1) (2021)
Zhen Zhang, Xinfeng Chen, Yonggui Tian, Feng Li, Xuan Zhao, Jinyan Liu, Chang Yao, Yi Zhang
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy. Journal for immunotherapy of cancer 8 (2) (2021)
Feng Li, Yuqiao Sheng, Weizhou Hou, Padma Sampath, Daniel Byrd, Stephen Thorne, Yi Zhang
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency. Journal for immunotherapy of cancer 8 (1) (2021)
Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Dong Huang, Feng Wang, Liping Wang, Song Zhao, Yi Zhang
NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma. Cancer biology & medicine (2021)
Jinyan Liu, Jingwen Shao, Chaoqi Zhang, Guohui Qin, Jiayin Liu, Miaomiao Li, Peng Wu, Xuan Zhao, Yi Zhang
Immuno-oncological role of 20S proteasome alpha-subunit 3 in aggravating the progression of esophageal squamous cell carcinoma. European journal of immunology (2021)
Wenyi Jiang, Jingyao Lian, Ying Yue, Yi Zhang
IL-33/ST2 as a potential target for tumor immunotherapy. European journal of immunology 51 (8) (2021)
Shasha Liu, Chaoqi Zhang, Boqiao Wang, Huanyu Zhang, Guohui Qin, Congcong Li, Ling Cao, Qun Gao, Yu Ping, Kai Zhang, Jingyao Lian, Qitai Zhao, Dan Wang, Zhen Zhang, Xuan Zhao, Li Yang, Lan Huang, Bo Yang, Yi Zhang
Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Xuan Zhao, Shasha Liu, Xinfeng Chen, Jianyi Zhao, Feng Li, Qitai Zhao, Tan Xie, Lan Huang, Zhen Zhang, Yu Qi, Yang Yang, Song Zhao, Yi Zhang
L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma. Cancer biology & medicine (2021)
Huanyu Zhang, Guohui Qin, Chaoqi Zhang, Huiyun Yang, Jinyan Liu, Hongwei Hu, Peng Wu, Shasha Liu, Li Yang, Xinfeng Chen, Xueke Zhao, Lidong Wang, Yi Zhang
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Weina Yu, Qingyang Lei, Li Yang, Guohui Qin, Shasha Liu, Dan Wang, Yu Ping, Yi Zhang
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. Journal of hematology & oncology 14 (1) (2021)
Shumin Wang, Yi Zhang
HMGB1 in inflammation and cancer. Journal of hematology & oncology 13 (1) (2020)
Lan Huang, Xuan Zhao, Yu Qi, Hong Li, Guanchao Ye, Yafei Liu, Yi Zhang, Jianjun Gou
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019. Cellular & molecular immunology 17 (10) (2020)
Ying Yue, Jingyao Lian, Tian Wang, Chenghan Luo, Yiqiang Yuan, Guohui Qin, Bin Zhang, Yi Zhang
Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells. Cancer science 111 (3) (2020)
Jingyao Lian, Saisai Liu, Ying Yue, Qingshan Yang, Zhen Zhang, Shengli Yang, Yi Zhang
Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway. Cancer science 112 (1) (2020)
Feifei Fan, Yu Ping, Li Yang, Xiaoran Duan, Nomathamsanqa Resegofetse Maimela, Bingjie Li, Xiangnan Li, Jing Chen, Kai Zhang, Liping Wang, Shasha Liu, Xuan Zhao, Hongmin Wang, Yi Zhang
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma. Journal of cellular and molecular medicine 24 (20) (2020)
Li Yang, Jianjun Gou, Jianbo Gao, Lan Huang, Zhiqiang Zhu, Shaofei Ji, Hongchun Liu, Lihua Xing, Mengying Yao, Yi Zhang
Immune characteristics of severe and critical COVID-19 patients. Signal transduction and targeted therapy 5 (1) (2020)
Feng Li, Zhen Zhang, Yujing Xuan, Daiqun Zhang, Jinyan Liu, Aitian Li, Shumin Wang, Ting Li, Xiaojuan Shi, Yi Zhang
PD-1 abrogates the prolonged persistence of CD8+ CAR-T cells with 4-1BB co-stimulation. Signal transduction and targeted therapy 5 (1) (2020)
Jingyao Lian, Ying Yue, Weina Yu, Yi Zhang
Immunosenescence: a key player in cancer development. Journal of hematology & oncology 13 (1) (2020)
Zhen Zhang, Feng Li, Yonggui Tian, Ling Cao, Qun Gao, Chaoqi Zhang, Kai Zhang, Chunyi Shen, Yu Ping, Nomathamsanqa Resegofetse Maimela, Liping Wang, Bin Zhang, Yi Zhang
Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 Pathway. Journal of immunology (Baltimore, Md. : 1950) 204 (9) (2020)
Yuying Liu, Yiliang Fang, Xinfeng Chen, Zhenfeng Wang, Xiao-Yu Liang, Tianzhen Zhang, Mengyu Liu, Nannan Zhou, Jiadi Lv, Ke Tang, Jing Xie, Yunfeng Gao, Feiran Cheng, Yabo Zhou, Zhen Zhang, Han Yan, Xiao-Hui Zhang, Quan-Li Gao, Yi Zhang, Bo Huang
Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Science immunology 5 (43) (2020)
Li Yang, Shasha Liu, Jinyan Liu, Zhixin Zhang, Xiaochun Wan, Bo Huang, Youhai Chen, Yi Zhang
COVID-19: immunopathogenesis and Immunotherapeutics. Signal transduction and targeted therapy 5 (1) (2020)
Dan Wang, Weina Yu, Jingyao Lian, Qian Wu, Shasha Liu, Li Yang, Feng Li, Lan Huang, Xinfeng Chen, Zhen Zhang, Aitian Li, Jinbo Liu, Zhenqiang Sun, Junxia Wang, Weitang Yuan, Yi Zhang
Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients. Journal of hematology & oncology 13 (1) (2020)
Yonggui Tian, Yilu Li, Yupei Shao, Yi Zhang
Gene modification strategies for next-generation CAR T cells against solid cancers. Journal of hematology & oncology 13 (1) (2020)
Chunyi Shen, Zhen Zhang, Yi Zhang
Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies. BioMed research international 2020 (2020)
Kai Zhang, Lei Zhang, Yang Mi, YouCai Tang, FeiFei Ren, Bin Liu, Yi Zhang, PengYuan Zheng
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer science 111 (11) (2020)
Chaoqi Zhang, Guochao Zhang, Nan Sun, Zhen Zhang, Liyan Xue, Zhihui Zhang, Haijun Yang, Yuejun Luo, Xiaoli Zheng, Yonglei Zhang, Yufen Yuan, Ruixue Lei, Zhaoyang Yang, Bo Zheng, Le Wang, Yun Che, Feng Wang, Sihui Wang, Shugeng Gao, Qi Xue, Yi Zhang, Jie He
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma. Signal transduction and targeted therapy 5 (1) (2020)
Feifei Ren, Qitai Zhao, Lan Huang, Yujia Zheng, Lifeng Li, Qianyi He, Chaoqi Zhang, Feng Li, Nomathamsanqa R Maimela, Zhi Sun, Qingquan Jia, Yu Ping, Zhen Zhang, Xinfeng Chen, Ying Yue, Shasha Liu, Ling Cao, Yi Zhang
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas. Immunology and cell biology 97 (5) (2019)
Dan Wang, Li Yang, Weina Yu, Qian Wu, Jingyao Lian, Feng Li, Shasha Liu, Aitian Li, Zhiang He, Jinbo Liu, Zhenqiang Sun, Weitang Yuan, Yi Zhang
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Journal for immunotherapy of cancer 7 (1) (2019)
Ting Sun, Qitai Zhao, Chaoqi Zhang, Ling Cao, Mengjia Song, Nomathamsanqa Resegofetse Maimela, Shasha Liu, Jinjin Wang, Qun Gao, Guohui Qin, Liping Wang, Yi Zhang
Screening common signaling pathways associated with drug resistance in non-small cell lung cancer via gene expression profile analysis. Cancer medicine 8 (6) (2019)
Xiaojuan Shi, Daiqun Zhang, Feng Li, Zhen Zhang, Shumin Wang, Yujing Xuan, Yu Ping, Yi Zhang
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity. Journal of hematology & oncology 12 (1) (2019)
Chenghan Luo, Mengyuan Lei, Yixia Zhang, Qian Zhang, Lifeng Li, Jingyao Lian, Shasha Liu, Liping Wang, Guofu Pi, Yi Zhang
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma. Journal of cellular and molecular medicine 24 (2) (2019)
Xuefei Gao, Monika Nowak-Imialek, Xi Chen, Dongsheng Chen, Doris Herrmann, Degong Ruan, Andy Chun Hang Chen, Melanie A Eckersley-Maslin, Shakil Ahmad, Yin Lau Lee, Toshihiro Kobayashi, David Ryan, Jixing Zhong, Jiacheng Zhu, Jian Wu, Guocheng Lan, Stoyan Petkov, Jian Yang, Liliana Antunes, Lia S Campos, Beiyuan Fu, Shengpeng Wang, Yu Yong, Xiaomin Wang, Song-Guo Xue, Liangpeng Ge, Zuohua Liu, Yong Huang, Tao Nie, Peng Li, Donghai Wu, Duanqing Pei, Yi Zhang, Liming Lu, Fengtang Yang, Susan J Kimber, Wolf Reik, Xiangang Zou, Zhouchun Shang, Liangxue Lai, M Azim Surani, Patrick P L Tam, Asif Ahmed, William Shu Biu Yeung, Sarah A Teichmann, Andres Hilfiker, Pengtao Liu
Establishment of porcine and human expanded potential stem cells. Nature cell biology 21 (6) (2019)
Zi Mei, Kai Zhang, Alfred King-Yin Lam, Junwen Huang, Feng Qiu, Bin Qiao, Yi Zhang
MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma. Cancer medicine 9 (2) (2019)
Ruinuo Jia, Li Yang, Xiang Yuan, Jinyu Kong, Yiwen Liu, Weijiao Yin, Shegan Gao, Yi Zhang
GASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter Demethylation. Journal of oncology 2019 (2019)
Li Yang, Aitian Li, Qingyang Lei, Yi Zhang
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Journal of hematology & oncology 12 (1) (2019)
Li Yang, Ying Dong, Yanjun Li, Dong Wang, Shasha Liu, Dan Wang, Qun Gao, Shaofei Ji, Xinfeng Chen, Qingyang Lei, Wenyi Jiang, Liping Wang, Bin Zhang, Jane J Yu, Yi Zhang
IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer. International journal of cancer 145 (4) (2019)
Qun Gao, Shumin Wang, Xinfeng Chen, Shaoyan Cheng, Zhen Zhang, Feng Li, Lan Huang, Yang Yang, Bin Zhou, Dongli Yue, Dan Wang, Ling Cao, Nomathamsanqa Resegofetse Maimela, Bin Zhang, Jane Yu, Liping Wang, Yi Zhang
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. Journal for immunotherapy of cancer 7 (1) (2019)

Yi Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yi Zhang